QRG Capital Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.9M Buy
25,169
+679
+3% +$141K 0.04% 308
2026
Q1
$5.5M Buy
24,490
+2,130
+10% +$531K 0.06% 264
2025
Q4
$5.39M Buy
22,360
+5,363
+32% +$1.37M 0.06% 238
2025
Q3
$4.65M Sell
16,997
-63,696
-79% -$17.4M 0.06% 251
2025
Q2
$20.8M Buy
80,693
+14,968
+23% +$3.57M 0.18% 126
2025
Q1
$14.7M Buy
65,725
+47,913
+269% +$11.2M 0.15% 149
2024
Q4
$4.07M Buy
17,812
+11,015
+162% +$2.65M 0.04% 325
2024
Q3
$1.66M Buy
6,797
+5,506
+426% +$1.23M 0.02% 477
2024
Q2
$247K Buy
1,291
+56
+5% +$11.4K ﹤0.01% 927
2024
Q1
$245K Buy
+1,235
New +$226K ﹤0.01% 956

Other funds holding RMD

QRG Capital Management's RMD Position: Q2 2026 in Review

QRG Capital Management increased its ResMed (RMD) stake by 2.8% in Q2 2026, buying an estimated $141K and bringing the position to 25,169 shares worth $4.9M. The position accounts for 0.04% of the portfolio, ranked #308.

QRG Capital Management first reported a position in RMD in Q1 2024 and has held it in 10 quarters since. The position peaked at $20.8M in Q2 2025. 880 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • QRG Capital Management held 25,169 shares of ResMed worth $4.9M as of Q2 2026.
  • QRG Capital Management bought 679 ResMed shares in Q2 2026, an estimated $141K.
  • ResMed made up 0.04% of QRG Capital Management's portfolio in Q2 2026, its #308 holding.
  • QRG Capital Management first reported a position in ResMed in Q1 2024 and has held it in 10 quarters since.
  • QRG Capital Management's ResMed position peaked at $20.8M in Q2 2025.
  • 880 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on QRG Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.